On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage ...
Based on results across various benchmarks, Claude 3.7 Sonnet is back in the lead in the white-hot race for AI supremacy, ...
Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it participated in the Virtual Investor "Top 5 for ...
Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the ...
“Analogue clock reading and calendar comprehension involve intricate cognitive steps: they demand fine-grained visual ...
Do you need to add LLM capabilities to your R scripts and applications? Here are three tools you'll want to know.
Explore key differences, creative applications, and whether the price increase is justified for your needs. Uncover GPT-4.5 ...
LAS VEGAS, March 10, 2025 /PRNewswire/ -- AI21, a pioneer in frontier models and AI systems, today unveiled Maestro, the ...
Anthropic is positioning Claude as the LLM that matters most for enterprise companies. Claude 3.7 Sonnet, released just two weeks ago, set new benchmark records for coding performance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback